These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26883917)

  • 21. Prostate cancer, comorbidity, and the risk of venous thromboembolism: A cohort study of 44,035 Danish prostate cancer patients, 1995-2011.
    Ording AG; Horváth-Puhó E; Lash TL; Ehrenstein V; Borre M; Vyberg M; Sørensen HT
    Cancer; 2015 Oct; 121(20):3692-9. PubMed ID: 26149752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis.
    Pedersen AB; Sorensen HT; Mehnert F; Overgaard S; Johnsen SP
    J Bone Joint Surg Am; 2010 Sep; 92(12):2156-64. PubMed ID: 20844157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obstetrical venous thromboembolism: Epidemiology and strategies for prophylaxis.
    Friedman AM; Ananth CV
    Semin Perinatol; 2016 Mar; 40(2):81-6. PubMed ID: 26742600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge of venous thromboembolism (VTE) prevention among hospitalized patients.
    Le Sage S; McGee M; Emed JD
    J Vasc Nurs; 2008 Dec; 26(4):109-17. PubMed ID: 19022169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary prevention of venous thromboembolism in long-term care: identifying and managing the risk.
    Haas S; Spyropoulos AC
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):149-58. PubMed ID: 18372276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
    Wiseman DN; Harrison J
    N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venous thromboembolism in patients with myeloma: incidence and risk factors in a "real-world" population.
    Crowley MP; Eustace JA; O'Shea SI; Gilligan OM
    Clin Appl Thromb Hemost; 2014 Sep; 20(6):600-6. PubMed ID: 24486624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venous thromboembolism in pregnancy.
    James AH
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):326-31. PubMed ID: 19228606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary prophylaxis of VTE in cancer outpatients.
    Imberti D; Benedetti R
    Thromb Res; 2016 Apr; 140 Suppl 1():S103-8. PubMed ID: 27067962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between red cell distribution width and risk of venous thromboembolism.
    Bucciarelli P; Maino A; Felicetta I; Abbattista M; Passamonti SM; Artoni A; Martinelli I
    Thromb Res; 2015 Sep; 136(3):590-4. PubMed ID: 26220270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of venous thromboembolism and primary prophylaxis in cancer. Should all patients receive thromboprophylaxis?
    Pabinger I; Ay C
    Hamostaseologie; 2012; 32(2):132-7. PubMed ID: 21822526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of thrombophilia according to age at the first manifestation of venous thromboembolism: results from the MAISTHRO registry.
    Weingarz L; Schwonberg J; Schindewolf M; Hecking C; Wolf Z; Erbe M; Weber A; Lindhoff-Last E; Linnemann B
    Br J Haematol; 2013 Dec; 163(5):655-65. PubMed ID: 24219332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous thromboembolism associated with acute cytomegalovirus infection: epidemiology and predisposing conditions.
    Yildiz H; Zech F; Hainaut P
    Acta Clin Belg; 2016 Aug; 71(4):231-4. PubMed ID: 27141959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of ENDORSE study in Hungary. Multinational, cross-sectional study to assess the prevalence of venous thromboembolism risk and prophylaxis in acute hospital care setting].
    Losonczy H; Tar A;
    Orv Hetil; 2008 Nov; 149(44):2069-76. PubMed ID: 18952526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deep venous thrombosis and venous thromboembolism prophylaxis.
    Buesing KL; Mullapudi B; Flowers KA
    Surg Clin North Am; 2015 Apr; 95(2):285-300. PubMed ID: 25814107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypercoagulability and venous thromboembolism in burn patients.
    Meizoso JP; Ray JJ; Allen CJ; Van Haren RM; Ruiz G; Namias N; Schulman CI; Pizano LR; Proctor KG
    Semin Thromb Hemost; 2015 Feb; 41(1):43-8. PubMed ID: 25590525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombophilia and risk of VTE recurrence according to the age at the time of first VTE manifestation.
    Weingarz L; Schindewolf M; Schwonberg J; Hecking C; Wolf Z; Erbe M; Lindhoff-Last E; Linnemann B
    Vasa; 2015 Jul; 44(4):313-23. PubMed ID: 26314364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venous thromboembolism in pregnancy: diagnosis, management and prevention.
    Chunilal SD; Bates SM
    Thromb Haemost; 2009 Mar; 101(3):428-38. PubMed ID: 19277402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism.
    Coppola A; Tufano A; Cerbone AM; Di Minno G
    Semin Thromb Hemost; 2009 Oct; 35(7):683-94. PubMed ID: 20013535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology, risk factors and sequelae of venous thromboembolism.
    Wong P; Baglin T
    Phlebology; 2012; 27 Suppl 2():2-11. PubMed ID: 22457300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.